Trial Profile
A PHASE IIa, RANDOMISED, DOUBLE-BLIND, MULTIPLE DOSE, PLACEBO CONTROLLED, 3 PERIOD CROSS-OVER, ASCENDING DOSE CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THREE DIFFERENT DOSES OF LAS100977, ADMINISTERED BY INHALATION DURING 7 DAYS TO STABLE ASTHMA PATIENTS
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2015
Price :
$35
*
At a glance
- Drugs Abediterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Almirall S.A.
- 03 Nov 2012 Planned patient number is 20 according to European Clinical Trials Database record.
- 27 Mar 2009 New trial record.